Quick Answer
Niagen Bioscience, Inc. reported Stockholders Equity of $76.53 million for the year ending 2025.
- Niagen Bioscience, Inc. showed an increase of +66.0% in Stockholders Equity from 2024 to 2025.
- This data is from Niagen Bioscience, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: $4.27 million | Q3 2013: $3.27 million | Q1 2014: $4.79 million | Q2 2014: $4.32 million | Q3 2014: $4.50 million | Q1 2015: $3.69 million | Q2 2015: $3.90 million | Q3 2015: $4.34 million | Q1 2016: $6.43 million | Q2 2016: $12.45 million | Q3 2016: $11.86 million | Q1 2017: $9.37 million | Q2 2017: $25.72 million | Q3 2017: $33.74 million | Q1 2018: $46.66 million | Q2 2018: $40.50 million | Q3 2018: $33.40 million | Q1 2019: $20.98 million | Q2 2019: $15.15 million | Q3 2019: $27.14 million | Q1 2020: $16.55 million | Q2 2020: $21.58 million | Q3 2020: $19.49 million | Q1 2021: $43.83 million | Q2 2021: $42.14 million | Q3 2021: $35.45 million | Q1 2022: $25.88 million | Q2 2022: $20.78 million | Q3 2022: $21.02 million | Q1 2023: $28.02 million | Q2 2023: $27.15 million | Q3 2023: $27.31 million | Q1 2024: $28.95 million | Q2 2024: $30.72 million | Q3 2024: $34.37 million | Q1 2025: $55.35 million | Q2 2025: $64.20 million | Q3 2025: $70.68 million.
- Over the full 17 years of available data (2009 to 2025), Niagen Bioscience, Inc.'s Stockholders Equity has grown by 7,206.6%.
- Historical annual values: Fiscal year 2025: $76.53 million | Fiscal year 2024: $46.09 million | Fiscal year 2023: $28.46 million | Fiscal year 2022: $28.67 million | Fiscal year 2021: $31.73 million | Fiscal year 2020: $16.42 million | Fiscal year 2019: $20.45 million | Fiscal year 2018: $27.18 million | Fiscal year 2017: $53.83 million | Fiscal year 2016: $9.97 million | Fiscal year 2015: $5.27 million | Fiscal year 2014: $4.00 million | Fiscal year 2013: $5.67 million | Fiscal year 2012: $3.99 million | Fiscal year 2011: $2.56 million | Fiscal year 2010: $4.94 million | Fiscal year 2009: $1.05 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: